Home Crystal structure of (Z)-3-(4-methoxyphenyl)-4-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-N-phenylthiazol-2(3H)-imine, C25H21N5OS
Article Open Access

Crystal structure of (Z)-3-(4-methoxyphenyl)-4-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-N-phenylthiazol-2(3H)-imine, C25H21N5OS

  • Bakr F. Abdel-Wahab , Saud A. Alanazi , Emad Yousif , Benson M. Kariuki and Gamal A. El-Hiti ORCID logo EMAIL logo
Published/Copyright: December 29, 2023

Abstract

C25H21N5OS, monoclinic, P21/n (no. 14), a = 12.9303(5) Å, b = 9.1111(4) Å, c = 18.7111(8) Å, β = 97.879(4)°, V = 2183.53(16) Å3, Z = 4, R gt (F) = 0.0487, wR ref (F2) = 0.1327, T = 293(2) K.

CCDC no.: 2314057

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.17 × 0.10 × 0.10 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 6.0 mm−1
Diffractometer, scan mode: Bruker APEXII, φ and ω
θmax, completeness: 56.6°, >99 %
N(hkl)measured, N(hkl)unique, Rint: 13,239, 9148, 0.025
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 7183
N(param)refined: 686
Programs: CrystAlisPRO [1], SHELX [2], WinGX/ORTEP [3], CHEMDRAW [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
C1 0.03708 (14) 0.8202 (2) 0.58167 (10) 0.0381 (4)
C2 0.02149 (17) 0.8323 (2) 0.65315 (11) 0.0465 (5)
H2 0.078034 0.840490 0.689431 0.056*
C3 −0.07936 (18) 0.8319 (2) 0.66978 (12) 0.0527 (5)
H3 −0.090937 0.840711 0.717563 0.063*
C4 −0.16260 (17) 0.8186 (2) 0.61607 (14) 0.0534 (5)
H4 −0.230188 0.816764 0.627804 0.064*
C5 −0.14671 (16) 0.8080 (3) 0.54508 (13) 0.0533 (5)
H5 −0.203530 0.799827 0.509007 0.064*
C6 −0.04606 (15) 0.8095 (3) 0.52713 (11) 0.0472 (5)
H6 −0.034824 0.803380 0.479181 0.057*
C7 0.14718 (17) 0.5873 (2) 0.49655 (13) 0.0520 (5)
H7A 0.100601 0.549008 0.527739 0.078*
H7B 0.202285 0.518070 0.493239 0.078*
H7C 0.109399 0.603970 0.449407 0.078*
C8 0.19250 (14) 0.7281 (2) 0.52637 (10) 0.0370 (4)
C9 0.29014 (14) 0.7883 (2) 0.52875 (10) 0.0370 (4)
C10 0.38571 (14) 0.7371 (2) 0.50277 (10) 0.0374 (4)
C11 0.47860 (15) 0.7321 (3) 0.54423 (10) 0.0452 (5)
H11 0.488089 0.753554 0.593280 0.054*
C12 0.49111 (13) 0.6638 (2) 0.41659 (10) 0.0360 (4)
C13 0.30245 (13) 0.6816 (2) 0.37593 (9) 0.0333 (4)
C14 0.23351 (14) 0.7963 (2) 0.35908 (10) 0.0403 (4)
H14 0.245273 0.886080 0.382397 0.048*
C15 0.14671 (15) 0.7776 (2) 0.30741 (11) 0.0438 (5)
H15 0.099693 0.854345 0.296742 0.053*
C16 0.13007 (14) 0.6446 (2) 0.27167 (10) 0.0394 (4)
C17 0.19949 (14) 0.5302 (2) 0.28807 (10) 0.0408 (4)
H17 0.188671 0.440945 0.264112 0.049*
C18 0.28517 (14) 0.5492 (2) 0.34031 (10) 0.0384 (4)
H18 0.331599 0.471952 0.351557 0.046*
C19 0.01870 (18) 0.4975 (3) 0.18771 (13) 0.0612 (6)
H19A 0.071844 0.470723 0.158993 0.092*
H19B −0.047461 0.503426 0.157511 0.092*
H19C 0.015101 0.424652 0.224382 0.092*
C20 0.61751 (14) 0.6008 (2) 0.34534 (9) 0.0401 (4)
C21 0.69189 (16) 0.7120 (3) 0.35746 (11) 0.0470 (5)
H21 0.673378 0.802522 0.374875 0.056*
C22 0.79308 (17) 0.6887 (3) 0.34376 (13) 0.0587 (6)
H22 0.842110 0.763633 0.351820 0.070*
C23 0.82140 (19) 0.5553 (4) 0.31831 (14) 0.0706 (8)
H23 0.889682 0.539351 0.309744 0.085*
C24 0.7486 (2) 0.4456 (3) 0.30558 (13) 0.0670 (7)
H24 0.767881 0.355497 0.288194 0.080*
C25 0.64659 (18) 0.4672 (3) 0.31826 (11) 0.0520 (5)
H25 0.597676 0.392473 0.308669 0.062*
N1 0.14152 (12) 0.82403 (18) 0.56448 (8) 0.0383 (4)
N2 0.20444 (13) 0.9371 (2) 0.59012 (10) 0.0481 (4)
N3 0.29442 (12) 0.9153 (2) 0.56804 (9) 0.0465 (4)
N4 0.39117 (11) 0.69774 (17) 0.43072 (8) 0.0358 (3)
N5 0.51235 (12) 0.6236 (2) 0.35497 (9) 0.0436 (4)
O1 0.04339 (11) 0.63654 (17) 0.22080 (8) 0.0553 (4)
S1 0.57902 (4) 0.68154 (7) 0.49731 (3) 0.04634 (16)

1 Source of material

A mixture of 4-methoxyaniline (0.62 g, 5 mmol) and phenyl isothiocyanate (0.68 g, 5 mmol) in anhydrous EtOH (15 ml), was refluxed for 15 min, followed by the addition of 2-bromo-1-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)ethan-1-one (1.2 g, 5 mmol). The mixture was refluxed for 4 h. The solid produced on standing overnight was filtered, dried, and recrystallized from DMF to give the title heterocycle in 80 % yield, mp 179–181 °C. IR (KBr): 3121, 1610, 1517 cm−1. 1H NMR (DMSO-d6): 2.17 (s, 3H, Me), 3.69 (s, 3H, OMe), 6.56 (s, 1H, thiazolyl), 6.88 (d, 8.2 Hz, 2H, Ar), 6.93 (d, 8.2 Hz, 2H, Ar), 7.00 (t, 7.7 Hz, 1H, Ar), 7.23 (d, 9.0 Hz, 2H, Ar), 7.29 (t, 7.7 Hz, 2H, Ar), 7.45–7.58 (m, 5H, Ar). 13C NMR (DMSO-d6): 9.5, 55.8, 100.6, 114.4, 121.5, 122.9, 125.2, 130.1, 130.2, 130.3, 130.5, 130.7, 130.9, 134.2, 135.8, 136.7, 152.1, 158.9, 159.4. Anal. Calcd. for C25H21N5OS (439.54): C, 68.32; H, 4.82; N, 15.93. Found: C, 68.43; H, 4.84; N, 16.08 %.

2 Experimental details

Hydrogen atoms were located in the difference Fourier map. Idealized geometries were subsequently used for the initial positions and a riding model applied during refinement. Methyl C–H bonds were fixed at 0.96 Å, with displacement parameters 1.5 times Uiso(C), and were allowed to spin about the C–C bond. C–H distances were set to 0.93 Å for sp2 hydrogen atoms and their U(iso) set to 1.2 times the Uiso(C). Crystal data, data collection and structure refinement details are summarized in Table 1.

3 Comment

Heterocycles containing the thiazol-2-imine moiety have been found to possess interesting biological activities [5], [6], [7]. In addition, triazoles show a wide range of activities against pathogens [8], [9], [10]. Therefore, synthesizing heterocycles containing N-phenylthiazol-2(3H)-imines and 1,2,3-triazoles has received attention [11, 12]. In previous work, we have reported the X-ray crystal structures of related heterocycles [13, 14].

The crystal structure is monoclinic, with an asymmetric unit comprising one molecule of C25H21N5OS (Figure 1) which is composed of the following five planar groups: phenyl (A: C1–C6), methyltriazole (B: C7–C9, N1–N3), thiazole (C: C10–C12, N4, S1), methoxybenzene (D:C13–C19, O1) and aniline (E: C20–C25, N5). The planes of adjacent groups in the molecule are significantly twisted relative to each other. The twist angles between the groups are: A/B = 55.21(7)°, B/C = 51.60(7)°, C/D = 55.87(7)° D/E = 45.69(5)°.

In the crystal structure, neighbouring molecules are related by inversion symmetry to form pairs with parallel thiazole groups with a CC centroid separated distance of 3.86 Å. The pairs of molecules are stacked to form columns parallel to the b-axis of the crystal. Adjoining columns are linked by C–H⋯O (C11⋯O1 = 3.506(2), C11–H11⋯O1 = 166.1) and C–H⋯N (C19⋯N3 = 3.504(3), C19–H19B⋯N3 = 165.0) interactions.


Corresponding author: Gamal A. El-Hiti, Cornea Research Chair Department of Optometry College of Applied Medical Sciences, King Saud University, P. O. Box 10219, Riyadh 11433, Saudi Arabia, E-mail:

  1. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Research funding: We thank the National Research Centre, Cairo, Egypt, and Cardiff University, Cardiff, UK, for their support. G. A. El-Hiti extends his appreciation to the Deanship of Scientific Research, King Saud University, for funding through the Vice Deanship of Scientific Research Chairs, Research Chair of Cornea.

References

1. Agilent CrysAlisPRO; Agilent Technologies: Yarnton, England, 2014.Search in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar PubMed

3. Farrugia, L. J. WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/s0021889812029111.Search in Google Scholar

4. Cambridge Soft. CHEMDRAW; Cambridge Soft Corporation: Cambridge, Massachusetts, USA, 2001.Search in Google Scholar

5. Sharma, P. C., Bansal, K. K., Sharma, A., Sharma, D., Deep, A. Thiazole-containing compounds as therapeutic targets for cancer therapy. Eur. J. Med. Chem. 2020, 188, 112016; https://doi.org/10.1016/j.ejmech.2019.112016.Search in Google Scholar PubMed

6. Ramachandran, S., Cheriyan, B. V., Aanandhi, M. V. Activities of thiazolidine-4-one and azetidine-2-one derivatives – a review. Res. J. Pharm. Technol. 2021, 14, 4513–4516; https://doi.org/10.52711/0974-360x.2021.00785.Search in Google Scholar

7. Arshad, M. F., Alam, A., Alshammari, A. A., Alhazza, M. B., Alzimam, I. M., Alam, M. A., Mustafa, G., Ansari, M. S., Alotaibi, A. M., Alotaibi, A. A., Kumar, S., Asdaq, S. M. B., Imran, M., Deb, P. K., Venugopala, K. V., Jomah, S. Thiazole: a versatile standalone moiety contributing to the development of various drugs and biologically active agents. Molecules 2022, 27, 3994; https://doi.org/10.3390/molecules27133994.Search in Google Scholar PubMed PubMed Central

8. Varala, R., Bollikolla, H. B., Kurmarayuni, C. M. Synthesis of pharmacological relevant 1,2,3-triazole and its analogues – a review. Curr. Org. Synth. 2021, 18, 101–124; https://doi.org/10.2174/18756271mta54otec0.Search in Google Scholar

9. Kazeminejad, Z., Marzi, M., Shiroudi, A., Kouhpayeh, S. A., Farjam, M., Zarenezhad, E. Novel 1,2,4-triazoles as antifungal agents. Biomed Res. Int. 2022, 2022, 4584846; https://doi.org/10.1155/2022/4584846.Search in Google Scholar PubMed PubMed Central

10. Marzi, M., Farjam, M., Kazeminejad, Z., Shiroudi, A., Kouhpayeh, A., Zarenezhad, E. A recent overview of 1,2,3-triazole-containing hybrids as novel antifungal agents: focusing on synthesis, mechanism of action, and structure-activity relationship (SAR). J. Chem. 2022, 2022, 7884316; https://doi.org/10.1155/2022/7884316.Search in Google Scholar

11. Abdel-Wahab, B. F., Kariuki, B. M., Mohamed, H. A., El-Hiti, G. A. Catalyst-free synthesis of novel 4-(benzofuran-2-yl)-N-phenylthiazol-2(3H)-imines, crystal structure elucidation, and the effect of phenyl substitution on crystal packing. Crystals 2023, 13, 1239; https://doi.org/10.3390/cryst13081239.Search in Google Scholar

12. Abdel-Wahab, B. F., Kariuki, B. M., Mohamed, H. A., Bekheit, M. S., Awad, H. M., El-Hiti, G. A. Synthesis and anticancer activity of 3-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehydes. J. Mol. Struct. 2023, 1294, 136528; https://doi.org/10.1016/j.molstruc.2023.136528.Search in Google Scholar

13. Geesi, M. H., Mohamed, H. A., Abdel-Wahab, B. F., Hegazy, A. S., Kariuki, B. M., El-Hiti, G. A. Crystal structure of ethyl 4-amino-5-(5-methyl-1-(4-tolyl)-1H-1,2,3-triazole-4-carbonyl)-2-p̆henylamino)thiophene-3-carboxylate, C24H23N5O3S. Z. Kristallogr. N. Cryst. Struct. 2018, 233, 673–674; https://doi.org/10.1515/ncrs-2018-0002.Search in Google Scholar

14. Basheen, M. A., Abdel-Wahab, B. F., Hegazy, A. S., Kariuki, B. M., El-Hiti, G. A. The crystal structure of 4-(4-bromophenyl)-2-(3-(4-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole, C24H16Br2FN3S. Z. Kristallogr. N. Cryst. Struct. 2021, 236, 425–427; https://doi.org/10.1515/ncrs-2020-0605.Search in Google Scholar

Received: 2023-11-18
Accepted: 2023-12-13
Published Online: 2023-12-29
Published in Print: 2024-02-26

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of poly[diaqua-(μ4-3,3′-di(1H-1,2,4-triazol-1-yl)-[1,1′-biphenyl]-4,4′-dicarboxylate-N:N′:O:O′)cadmium(II)], C18H14N6O6Cd
  4. Crystal structure of (8R,8′S,13S,13′R)-8,8′-bis(hydroxymethyl)-9,9′,10,10′-tetramethoxy-5,5′,6,6′,8,8′,13,13′-octahydro-[13,13′-bi[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline]-7,7′-diium chloride-methanol (1/2), C46H58N2O14Cl2
  5. The crystal structure of 8-methoxy-2,2-diphenyl-tosyl-1,2-dihydro-2λ4,3λ4-[1,3,2]diazaborolo[4,5,1-ig]quinoline, C29H25BN2O3S
  6. Crystal structure of aqua-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N‴)copper(II) 5-carboxyisophthalate tetrahydrate, C25H50N4CuO11
  7. The crystal structure of 1-(naphthalen-2-ylsulfonyl)-2,2-diphenyl-1,2-dihydro-2λ4,3λ4-[1,3,2]diazaborolo[4,5,1-ij]quinoline, C31H23BN2O2S
  8. Crystal structure of iodido-(η6-benzene) (1-(pyridin-2-yl)-N-(p-fluoro-methanamine)-κ2N,Nʹ)ruthenium(II) hexaflourophosphate, (C18H15F7IN2RuP)
  9. The crystal structure of 1-(3-oxo-1-phenyl-3-(p-tolyl) propylidene)-1,3-dihydro-2H-inden-2-one, C25H20O2
  10. Crystal structure of tricyclohexyl[4-(4H-1,2,4-triazol-4-yl)-benzoato-κO]tin(IV), C27H39N3O2Sn
  11. Crystal structure of [triaqua-(8-carboxymethoxy-quinoline-2-carboxylate-κ4N,O,O,O)cadmium(II)]monohydrate, C12H15NO9Cd
  12. Crystal structure of ethyl 2-((4-(3,5-dimethylisoxazol-4-yl)-2,6-difluorophenyl)amino)benzoate, C20H18F2N2O3
  13. The crystal structure of 2-(hydroxymethyl)-2-(4H-1,2,4-triazol-4-yl)propane-1,3-diol, C6H11N3O3
  14. The crystal structure of 1,2-bis(2,4-dinitrophenyl) hydrazine, C12H8N6O8
  15. Crystal structure of 1-(2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)-1,2-dihydro-4H-benzo[d][1,3]oxazin-4-one, C19H14Cl2N2O3
  16. The crystal structure of 5-amino-5-oxo-4-(1-oxo-4-(2-oxopyrrolidin-1-yl)isoindolin-2-yl)pentanoic acid, C17H19N3O5
  17. Crystal structure of N2,N6-bis(2-(((Z)-5-bromo-2-hydroxybenzylidene)amino) phenyl)pyridine-2,6-dicarboxamide, C33H23Br2N5O4
  18. The crystal structure of (E)-2-methoxy-6-(((5-methyl-1,3,4-thiadiazol-2-yl)imino)methyl)phenol, C11H11N3O2S
  19. The crystal structure of 3-((tert-butyldiphenylsilyl)methyl)-5,5-diphenyl-6-(p-tolyl) tetrahydro-2H-pyran-2-one, C41H42O2Si
  20. Crystal structure of 9-fluoro-4-(6-methoxypyridin-3-yl)-5,6-dihydrobenzo[h]quinazolin-2-amine, C18H15FN4O
  21. The crystal structure of 2-bromo-5-(4-cyanophenoxy)benzyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate, C21H19BrN2O3
  22. Crystal structure of 3,3′-(1,4-phenylenebis(methylene))bis(1-isopropyl-1H-imidazol-3-ium) bis(hexafluorophosphate(V)), C10H14F6N2P
  23. The crystal structure of 2,2-di(thiophen-3-yl)-1-tosyl-1,2-dihydro-2λ4,3λ4-[1,3,2]diazaborolo[4,5,1-ig]quinoline, C24H19BN2O2S3
  24. Crystal structure of 5-bromo-1-(2-iodobenzoyl)-1H-indole-3-carbaldehyde, C16H9BrINO2
  25. The crystal structure of monocarbonyl-2-carboxypyridinato-κ2N,O-triphenylphosphine-rhodium(I) acetonitrile solvate, C26H20.50N1.50O3PRh
  26. Crystal structure of dichlorido-tetrakis(1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ1N)manganese(II), C60H68O4N12Cl10Mn
  27. Crystal structure of 3-(tert-butyldiphenylsilyl)-1-(2,6-dichlorophenyl)-2,2-diphenylpropan-1-ol, C37H36Cl2OSi
  28. Crystal structure of langite from Mine du Pradet (France)
  29. The crystal structure of 5′-(furan-2-yl)-3′-((4-methylphenyl)sulfonamido)-3′,4′,5′,6′-tetrahydro-[1,1′:3′,1″-terphenyl]-4′-carboxylic acid, C30H27NO5S
  30. Synthesis and crystal structure of bis{2-(((4-acetophenone)imino)methyl)-4-fluorophenolato-κ2N,O}zinc(II), C30H22F2N2O4Zn
  31. The crystal structure of poly[(tripyridine-κ3N,N′,N″) μ3-(pyridine-3,4-dicarboxylate-κ3N:O:O′) manganese(II)], C22H22N4O8Mn
  32. The crystal structure of (E)-4-chloro-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H15ClN2O2
  33. Synthesis and crystal structure of bis{2-(tert-butyl)-6-((E)-((4-((E)-1-(methoxyimino) ethyl)phenyl)imino)methyl)phenolato-κ2N,O}cobalt(II), C40H46CoN4O4
  34. Crystal structure of tetraaqua-[(1-(carboxymethyl)-1H-pyrazole-3-carboxylato-κ2N,O)cobalt(II)], C6H12CoN2O8
  35. (6R,7S)-2,3,13-trimethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3′,4′]cycloocta [1′,2′:4,5]benzo[1,2-d][1,3]dioxol-1-ol, C22H26O6
  36. Crystal structure of 2-((2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)benzoic acid, C18H14Cl2N2O3
  37. Crystal structure of (5aS,6aS,8aR,9R,11aS, 11bS,13R,13aS)-1,1,8a,11a-tetramethyl-9-((S)-1-((S)-5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3-oxo-1,7,8,8a,9,10,11,11a,11b,12,13,13a-dodecahydro-3H,6H-cyclopenta[5,6]cyclopropa[1,8a]naphtho[2,1-c]oxepin-13-yl acetate, C32H44O6
  38. Crystal structure of catena-poly[triaqua-(μ2-1-(4-carboxylatophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylato-O,O′:O″)cobalt(II)], C12H12N2O8Co
  39. Crystal structure of 3-[(furan-2-ylmethyl)-amino]-2-(2,3,4,5-tetrafluoro-benzoyl)-acrylic acid ethyl ester, C17H13F4NO4
  40. Crystal structure of methyl 4-(2-ethoxy-2-oxoethoxy)-3-methoxybenzoate, C13H16O6
  41. Crystal structure of 4-bromo-2-(4-chlorophenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, C13H7BrClF3N2
  42. The crystal structure of triaqua-(8-carboxymethoxy-quinoline-2-carboxylate-κ3N,O,O)nickel(II) monohydrate, C12H15NO9Ni
  43. Crystal structure of dihydroxy(2,4,6-triisopro-pylphenyl)telluronium trifluoromethanesulfonate, C16H25F3O5STe
  44. The crystal structure of 1-(carboxymethyl)-1H-imidazole 3-oxide
  45. The crystal structure of 1,3,5-tris(dibromomethyl)benzene, C9H6Br6
  46. Crystal structure of (Z)-3-(4-methoxyphenyl)-4-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-N-phenylthiazol-2(3H)-imine, C25H21N5OS
  47. Crystal structure of (Z)-3-(3-(4-hydroxyphenyl)-2-(phenylimino)-2,3-dihydrothiazol-4-yl)-2H-chromen-2-one, C24H16N2O3S
Downloaded on 15.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0503/html?srsltid=AfmBOoq5zuDS3TfcjMM1fJXeFf7_w-kXU35SVA48J-ByG8KIHo21z-ox
Scroll to top button